Target intelligence / Profile preview

Residual cariogenic bacteria

Molecular classification
Pathogen, Microorganism, Biofilm
01

Overview

Residual cariogenic bacteria refer to the diverse community of acid-producing microorganisms, primarily Streptococcus mutans and Lactobacillus species, that remain within the dentinal tubules or the floor of a cavity after the removal of carious tissue (Takahashi & Nyvad, 2011; Conrads et al., 2019). These bacteria possess the ability to survive in low-oxygen, nutrient-poor environments by metabolizing residual carbohydrates into organic acids, which further demineralizes the tooth structure (Takahashi & Nyvad, 2011). Their presence is a significant clinical concern as they can lead to secondary caries, restoration failure, and the progression of infection into the dental pulp (Schwendicke et al., 2016; Maltz et al., 2013). Therapeutic strategies involve the use of cavity disinfectants, such as chlorhexidine or silver diamine fluoride, which aim to eradicate these pathogens or inhibit their metabolic activity (Mei et al., 2013). Modern restorative materials may also incorporate antimicrobial agents to provide long-term suppression of these residual populations (Mei et al., 2013). Understanding the composition and survival mechanisms of this microbiota is essential for the success of minimally invasive dentistry and the preservation of tooth vitality (Schwendicke et al., 2016).

Other names
Residual bacteriaCariogenic microfloraDentin-invading bacteriaInfected dentin microbiotaResidual bacteria in carious dentin
02

Mechanism of action

Drugs targeting these bacteria typically act through the disruption of bacterial cell membranes, inhibition of essential metabolic enzymes such as enolase, and interference with bacterial adhesion and biofilm maturation.

03

Biological functions

AcidogenesisAciduric metabolismBiofilm formationExtracellular polysaccharide synthesisBacterial adhesion
04

Disease associations

Dental cariesPulpitisSecondary cariesApical periodontitisRestoration failure
05

Safety considerations

Pulpal irritation and cytotoxicityTooth staining and discolorationDevelopment of antimicrobial resistanceIncomplete eradication leading to recurrent infectionAllergic reactions to antimicrobial agents
06

Interacting drugs

Chlorhexidine

7 more in the full profile.

07

Biomarkers

Colony forming units (CFU)Bacterial DNA concentration (16S rRNA)ATP bioluminescenceLactic acid concentrationFluorescence-based metabolic activity

Beyond the preview

Go deeper on Residual cariogenic bacteria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Residual cariogenic bacteria.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call